Showing results (1631-1640 of 1,991) with videos related to

Sort By:
Pageof 200
Cell Communication and Signaling : CCS|September 17, 2021
R-Ras subfamily proteins elicit distinct physiologic effects and phosphoproteome alterations in neurofibromin-null MPNST cellsShannon M Weber, Nicole M Brossier, Amanda Prechtl, et al.
Global Change Biology|January 26, 2024
Carbon sequestration in the subsoil and the time required to stabilize carbon for climate change mitigationCarlos A Sierra, Bernhard Ahrens, Martin A Bolinder, et al.
The Western Journal of Emergency Medicine|September 24, 2020
Post-traumatic Stress Disorder in Family-witnessed Resuscitation of Emergency Department PatientsMert Erogul, Antonios Likourezos, Jodee Meddy, et al.
Clinical Pharmacology and Therapeutics|June 9, 2022
Exposure of Fexofenadine, but Not Pseudoephedrine, Is Markedly Decreased by Green Tea Extract in Healthy VolunteersShingen Misaka, Yuko Ono, R Verena Taudte, et al.
Pharmacogenetics|May 29, 2004
Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liverThomas Lang, Monika Hitzl, Oliver Burk, et al.
Clinical Pharmacokinetics|April 11, 2008
Determinants of steady-state torasemide pharmacokinetics: impact of pharmacogenetic factors, gender and angiotensin II receptor blockersDierk Werner, Ulrike Werner, Annett Meybaum, et al.
Annals of Emergency Medicine|May 31, 2025
Stroke Sensitivity Calculation in Medical Emergency Calls and Factors Associated With Stroke Suspicion: A Retrospective Registry-Based StudyEmil Iversen, Hege Ihle-Hansen, Kari Krizak Halle, et al.
American Heart Journal|January 25, 2008
Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trialGiovanni Pedrazzini, Eugenio Santoro, Roberto Latini, et al.
Clinical Pharmacology and Therapeutics|May 21, 2005
Grapefruit juice ingestion significantly reduces talinolol bioavailabilityUte I Schwarz, Diana Seemann, Reinhard Oertel, et al.
The International Journal of Artificial Organs|October 17, 2008
Combating implant infections. Remarks by a women's teamC R Arciola, N Balaban, L Baldassarri, et al.
Pageof 200